"He who cures a disease may be [the most skillful], but he that prevents it is the safest physician." — Thomas Fuller, English churchman and historian.
- A look at vaccine immune response
- COVID-19 antibodies study
- Post-infection treatment for COVID
- COVID-19 and the immunocompromised
- Treatments for Type 2 diabetes
- New device for cranial reconstruction
- Hope for recurrent bladder cancer
- $30M grant for tech for the aging
- $2M for RAZOR Medical Instruments
- Gene-therapy manufacturing talent
July 14, 2021
A look at vaccine immune response
COVID-19 antibodies study
DETROIT, MI—Beaumont Health, Southeast Michigan’s largest health care system, has launched a two-year study designed to better understand how a person develops vaccine-induced COVID-19 antibodies and how long those antibodies last.
Post-infection treatment for COVID
MANHATTAN, KANSAS—Kansas State University researchers have published a study that demonstrates successful post-infection treatment for SARS-CoV-2. College of Veterinary Medicine researchers found that animal models infected with SARS-CoV-2 and treated with an inhibitor of protease enzymes had significantly increased survival rates and decreased lung viral quantities.
COVID-19 and the immunocompromised
PITTSBURGH, PA—Researchers from the University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center in Pennsylvania say that immunocompromised patients are at an increased risk for severe and protracted illness following infection with SARS-CoV-2. The analysis involved 107 health care personnel and 489 immunocompromised patients who had been fully immunized with the Moderna, Pfizer-BioNTech or the Johnson & Johnson vaccine.
Flyover Future has followed medical and tech news around COVID-19 from the beginning of the pandemic. We’re adding coverage to this report related to health care innovation to feature more advances across Flyover Country.
- KANSAS CITY, KS—A study at the University of Kansas Medical Center will be investigating Fosciclopirox for the treatment of newly diagnosed and recurrent bladder cancer. The study, funded by the National Cancer Institute, will include 12 patients who will receive a dose of the drug intravenously 20 minutes once daily.
- INDIANAPOLIS, IN—Indiana University’s National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD) has been awarded a $30 million grant from the National Institute on Aging. Since 2018, NCRAD has been among the five largest grants awarded to the IU School of Medicine.
- WARSAW, IN—RAZOR Medical Instruments has raised over $2 million in a Series A funding round by Indy-based Elevate Ventures and several angel investors. RAZOR develops single-use medical instruments that help keep patients from contracting infection from orthopedic surgery.
Share stories, offer suggestions or leave a comment!